Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway.

Lung cancer is the leading cause of cancer-related death in China and worldwide[1].Although the popularization and application of PET-CT have improved the detection rate of patients with early lung cancer,there is still a lack of effective drugs to prevent and treat lung cancer metastasis and prolong the survival of patients[2,3].